RANI: Rani Therapeutics Holdings Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Rani Therapeutics Holdings Inc (RANI).
$78.49M Market Cap.
RANI Market Cap. (MRY)
RANI Shares Outstanding (MRY)
RANI Assets (MRY)
Total Assets
$36.63M
Total Liabilities
$33.14M
Total Investments
$23.88M
RANI Income (MRY)
Revenue
$1.03M
Net Income
-$30.02M
Operating Expense
$54.34M
RANI Cash Flow (MRY)
CF Operations
-$35.50M
CF Investing
$19.81M
CF Financing
$13.59M
RANI Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $36,634,000 (-36.75%) | $57,916,000 (-46.39%) | $108,027,000 (-13.03%) | $124,207,000 (56.40%) |
Assets Current | $29,744,000 (-41.50%) | $50,847,000 (-49.62%) | $100,924,000 (-15.61%) | $119,595,000 (59.58%) |
Assets Non-Current | $6,890,000 (-2.53%) | $7,069,000 (-0.48%) | $7,103,000 (54.01%) | $4,612,000 (3.18%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $1,992,000 (-84.52%) | $12,866,000 (-65.09%) | $36,855,000 (-22.26%) | $47,411,000 (141.83%) |
Property Plant & Equipment Net | $6,644,000 (-2.62%) | $6,823,000 (-3.94%) | $7,103,000 (54.01%) | $4,612,000 (3.18%) |
Cash & Equivalents | $3,762,000 (-35.85%) | $5,864,000 (-78.29%) | $27,007,000 (-77.01%) | $117,453,000 (60.77%) |
Accumulated Other Comprehensive Income | $5,000 (141.67%) | -$12,000 (83.56%) | -$73,000 (0%) | $0 (0%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $23,877,000 (-44.05%) | $42,675,000 (-40.29%) | $71,475,000 (0%) | $0 (0%) |
Investments Current | $23,877,000 (-44.05%) | $42,675,000 (-40.29%) | $71,475,000 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $1,359,000 (109.72%) | $648,000 (-55.62%) | $1,460,000 (21.06%) | $1,206,000 (76.83%) |
Accumulated Retained Earnings (Deficit) | -$102,907,000 (-41.18%) | -$72,889,000 (-87.28%) | -$38,919,000 (-367.16%) | -$8,331,000 (92.69%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $29,709,000 (-1.30%) | $30,099,000 (-0.38%) | $30,214,000 (0%) | $0 (0%) |
Debt Current | $16,459,000 (193.13%) | $5,615,000 (458.15%) | $1,006,000 (0%) | $0 (0%) |
Debt Non-Current | $13,250,000 (-45.88%) | $24,484,000 (-16.17%) | $29,208,000 (0%) | $0 (0%) |
Total Liabilities | $33,141,000 (2.06%) | $32,473,000 (-4.56%) | $34,023,000 (1188.75%) | $2,640,000 (-67.16%) |
Liabilities Current | $19,891,000 (148.98%) | $7,989,000 (65.92%) | $4,815,000 (82.39%) | $2,640,000 (-50.26%) |
Liabilities Non-Current | $13,250,000 (-45.88%) | $24,484,000 (-16.17%) | $29,208,000 (0%) | $0 (0%) |
RANI Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $1,028,000 (0%) | $0 (0%) | $0 (0%) | $2,717,000 (488.10%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $23,946,000 (-9.55%) | $26,475,000 (-1.37%) | $26,844,000 (-3.56%) | $27,834,000 (460.94%) |
Research & Development Expense | $26,682,000 (-32.66%) | $39,624,000 (8.24%) | $36,607,000 (38.23%) | $26,482,000 (119.88%) |
Operating Expenses | $54,342,000 (-17.79%) | $66,099,000 (4.17%) | $63,451,000 (16.82%) | $54,316,000 (219.39%) |
Interest Expense | $5,033,000 (-1.02%) | $5,085,000 (374.79%) | $1,071,000 (129.83%) | $466,000 (275.81%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $70,000 (70.73%) | $41,000 (17.14%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$56,584,000 (16.64%) | -$67,883,000 (-7.17%) | -$63,344,000 (-19.32%) | -$53,088,000 (-58.92%) |
Net Income to Non-Controlling Interests | -$26,566,000 (21.66%) | -$33,913,000 (-3.53%) | -$32,756,000 (26.81%) | -$44,757,000 (-167.96%) |
Net Income | -$30,018,000 (11.63%) | -$33,970,000 (-11.06%) | -$30,588,000 (-267.16%) | -$8,331,000 (50.12%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$30,018,000 (11.63%) | -$33,970,000 (-11.06%) | -$30,588,000 (-267.16%) | -$8,331,000 (50.12%) |
Weighted Average Shares | $28,476,000 (11.65%) | $25,505,000 (7.09%) | $23,817,000 (21.93%) | $19,534,000 (-58.34%) |
Weighted Average Shares Diluted | $28,476,000 (11.65%) | $25,505,000 (7.09%) | $23,817,000 (21.93%) | $19,534,000 (-58.34%) |
Earning Before Interest & Taxes (EBIT) | -$24,985,000 (13.50%) | -$28,885,000 (1.91%) | -$29,447,000 (-276.37%) | -$7,824,000 (52.71%) |
Gross Profit | $1,028,000 (0%) | $0 (0%) | $0 (0%) | $2,717,000 (488.10%) |
Operating Income | -$53,314,000 (19.34%) | -$66,099,000 (-4.17%) | -$63,451,000 (-22.97%) | -$51,599,000 (-211.89%) |
RANI Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | $19,809,000 (-33.66%) | $29,860,000 (141.22%) | -$72,436,000 (-14215.42%) | -$506,000 (57.83%) |
Net Cash Flow from Financing | $13,585,000 (5730.47%) | $233,000 (-99.20%) | $29,005,000 (-62.40%) | $77,146,000 (6.14%) |
Net Cash Flow from Operations | -$35,496,000 (30.72%) | -$51,236,000 (-10.15%) | -$46,515,000 (-44.25%) | -$32,245,000 (-115.54%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$2,102,000 (90.06%) | -$21,143,000 (76.49%) | -$89,946,000 (-302.60%) | $44,395,000 (-21.46%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $20,077,000 (-35.42%) | $31,089,000 (143.90%) | -$70,817,000 (0%) | $0 (0%) |
Capital Expenditure | -$268,000 (78.19%) | -$1,229,000 (24.09%) | -$1,619,000 (-219.96%) | -$506,000 (57.83%) |
Issuance (Repayment) of Debt Securities | -$5,000,000 (0%) | $0 (0%) | $29,314,000 (741.73%) | -$4,568,000 (-213.21%) |
Issuance (Purchase) of Equity Shares | $18,632,000 (4616.96%) | $395,000 (24.61%) | $317,000 (-99.57%) | $73,674,000 (0%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $16,031,000 (-15.66%) | $19,008,000 (20.44%) | $15,782,000 (-30.15%) | $22,595,000 (0%) |
Depreciation Amortization & Accretion | $2,837,000 (52.28%) | $1,863,000 (42.00%) | $1,312,000 (163.98%) | $497,000 (-15.62%) |
RANI Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 100.00% | - | - | 100.00% (0.00%) |
Profit Margin | -2920.00% | - | - | -306.60% (91.52%) |
EBITDA Margin | -2154.50% | - | - | -269.70% (92.19%) |
Return on Average Equity (ROAE) | -782.50% (-390.90%) | -159.40% (-134.76%) | -67.90% (-392.67%) | 23.20% (45.91%) |
Return on Average Assets (ROAA) | -67.70% (-53.51%) | -44.10% (-56.94%) | -28.10% (-255.70%) | -7.90% (75.77%) |
Return on Sales (ROS) | -2430.40% | - | - | -288.00% (91.96%) |
Return on Invested Capital (ROIC) | -45.00% (-42.41%) | -31.60% (45.70%) | -58.20% (79.95%) | -290.30% (31.50%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% |
Price to Earnings Ratio (P/E) | -1.3 (47.72%) | -2.5 (45.85%) | -4.61 (87.88%) | -38.02 |
Price to Sales Ratio (P/S) | 37.95 | - | - | 117.55 |
Price to Book Ratio (P/B) | 39.4 (205.40%) | 12.9 (63.26%) | 7.9 (-53.24%) | 16.9 |
Debt to Equity Ratio (D/E) | 16.64 (559.15%) | 2.52 (173.46%) | 0.92 (1548.21%) | 0.06 (178.87%) |
Earnings Per Share (EPS) | -1.05 (21.05%) | -1.33 (-3.91%) | -1.28 (-197.67%) | -0.43 (-19.44%) |
Sales Per Share (SPS) | 0.04 (0%) | 0 (0%) | 0 (0%) | 0.14 (1290.00%) |
Free Cash Flow Per Share (FCFPS) | -1.26 (38.94%) | -2.06 (-1.78%) | -2.02 (-20.51%) | -1.68 (-386.09%) |
Book Value Per Share (BVPS) | 0.07 (-86.11%) | 0.5 (-67.42%) | 1.55 (-36.26%) | 2.43 (200.41%) |
Tangible Assets Book Value Per Share (TABVPS) | 1.29 (-43.37%) | 2.27 (-49.93%) | 4.54 (-28.67%) | 6.36 (275.38%) |
Enterprise Value Over EBIT (EV/EBIT) | -4 (42.86%) | -7 (22.22%) | -9 (89.53%) | -86 |
Enterprise Value Over EBITDA (EV/EBITDA) | -4.87 (31.15%) | -7.08 (28.59%) | -9.91 (89.18%) | -91.64 |
Asset Turnover | 0.02 (0%) | 0 (0%) | 0 (0%) | 0.03 (188.89%) |
Current Ratio | 1.5 (-76.51%) | 6.37 (-69.63%) | 20.96 (-53.73%) | 45.3 (220.85%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$35,764,000 (31.83%) | -$52,465,000 (-9.00%) | -$48,134,000 (-46.97%) | -$32,751,000 (-102.67%) |
Enterprise Value (EV) | $107,940,494 (-43.57%) | $191,298,407 (-31.41%) | $278,898,991 (-58.46%) | $671,444,033 |
Earnings Before Tax (EBT) | -$30,018,000 (11.63%) | -$33,970,000 (-11.31%) | -$30,518,000 (-268.13%) | -$8,290,000 (50.26%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$22,148,000 (18.04%) | -$27,022,000 (3.96%) | -$28,135,000 (-283.99%) | -$7,327,000 (54.08%) |
Invested Capital | $42,690,000 (-42.44%) | $74,162,000 (-30.31%) | $106,419,000 (2486.75%) | $4,114,000 (-14.65%) |
Working Capital | $9,853,000 (-77.01%) | $42,858,000 (-55.41%) | $96,109,000 (-17.82%) | $116,955,000 (67.95%) |
Tangible Asset Value | $36,634,000 (-36.75%) | $57,916,000 (-46.39%) | $108,027,000 (-13.03%) | $124,207,000 (56.40%) |
Market Capitalization | $78,485,494 (-52.72%) | $165,988,407 (-43.00%) | $291,224,991 (-63.65%) | $801,187,033 |
Average Equity | $3,836,250 (-82.00%) | $21,308,750 (-52.71%) | $45,061,500 (225.72%) | -$35,842,000 (65.86%) |
Average Assets | $44,353,000 (-42.46%) | $77,076,250 (-29.27%) | $108,970,500 (3.64%) | $105,140,750 (105.28%) |
Invested Capital Average | $55,505,750 (-39.29%) | $91,421,000 (80.68%) | $50,598,750 (1777.16%) | $2,695,500 (-30.96%) |
Shares | 57,288,682 (14.59%) | 49,996,508 (1.29%) | 49,360,168 (0.73%) | 49,002,265 (2.39%) |
